节点文献

RNA干扰治疗肝纤维化的实验研究

The experimental research of RNA interference therapy in hepatic fibrosis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 徐威詹娜王鲁文

【Author】 XU Wei,ZHAN Na,WANG Lu- wen.* Department of Internal Medicine,People’s Hospital of Wuhan University,Wuhan 430060,China

【机构】 武汉大学人民医院内科武汉大学人民医院病理科武汉大学人民医院感染科

【摘要】 目的观察转化生长因子(TGF-β1)小干扰RNA(siRNA)对小鼠免疫性肝纤维化的阻断作用。方法设计3条针对TGF-β1不同靶位的短发夹RNA(shRNA),以及1条无关对照序列(HK),克隆至pGenesil-1质粒中,构建重组真核表达载体pGenesil-TGF-β1-m1、pGenesil-TGF-β1-m2、pGenesil-TGF-β1-m3和pGenesil-HK。30只雄性昆明小白鼠随机分为6组:正常组、模型组、无关序列对照组(pGenesil-HK)、序列1治疗组(pGenesil-TGF-β1-m1)、序列2治疗组(pGenesil-TGF-β1-m2)、序列3治疗组(pGenesil-TGF-β1-m3)。采用尾静脉注射刀豆蛋白A(Con A)制备免疫性肝纤维化动物模型。3个序列治疗组、无关序列对照组分别于第2、4、6周,在Con A注射后24 h内,尾静脉高压注射pGenesil-TGF-β1-m1、pGenesil-TGF-β1-m2、pGenesil-TGF-β1-m3和pGenesil-HK。第7周处死全部小鼠。常规生化方法测定肝组织羟脯氨酸(HYP)含量;应用半定量RT-PCR技术检测肝组织内TGF-β1、Smad3、Smad7、α-平滑肌肌动蛋白(α-SMA)mRNA的表达。结果治疗组小鼠HYP较模型组明显降低(P<0.01);RT-PCR显示治疗组肝脏内TGF-β1、Smad3及α-SMA mRNA表达较模型组明显降低(P<0.01),而Smad7 mRNA表达增强(P<0.01)。在3个治疗组中,pGenesil-TGF-β1-m1治疗组的疗效最佳。结论 TGF-β1 siRNA能有效抑制小鼠免疫性肝纤维化的发生,其机制可能是抑制肝内TGF-β1、Smad3及α-SMA表达,并促进Smad7表达,从而下调HSC的激活信号,减少胶原合成。

【Abstract】 Objective To investigate the inhibitory effect of siRNA targeted against transforming factorβ1 (TGF-β1) in mice with immune hepatic fibrosis induced by Concanavalin A(Con A).Methods Three short hairpin RNAs(shRNAs) targeting different positions of TGF-β1 were designed and cloned to a plasmid pGenesil-1 respectively to obtain three recombinant expression vectors(pGenesil-TGF-β1-m1,pGenesil-TGF-β1-m2 and pGenesil-TGF -β1-m3).Thirty male Kunming mice were randomly divided into 6 groups;normal group,model group,control group(pGenesil-HK) and three treatment groups(pGenesil-TGF-β1-m1,pGenesil-TGF-β1-m2 and pGenesil-TGF-β1 -m3).The immune hepatic fibrosis animal models were constructed by injecting Con A via the tail vein of mice that continued for 6 weeks.At the 2nd,4th and 6th weeks,three treatment groups were injected hydrodynamics based on transfection method via the tail vein within 24hrs after injection of Con A respectively.All of the mice were sacrificed at the 7th week.The levels of hydroxyproline(HYP) in liver tissue were examined by biochemistry method. The expressions of TGF-β1,Smad3,Smad7 andα-smooth muscle actin(α-SMA) mRNA in the liver were detected by semi quantitative RT-PCR.Results The levels of HYP of liver tissue in treatment groups were significantly lower than that in model group(P<0.01).The results of RT-PCR showed that the expression levels of TGF-β1, Smad3 andα-SMA mRNA were inhibited in treatment groups compared with model group(P<0.01),while the levels of Smad7 were increased(P<0.01).The inhibition effect of pGenesil-TGF-β1-m1 was the best among three treatment groups.Conclusion It is suggested that specific siRNA targeting TGF-β1 inhibite the liver fibrogenesis of immune hepatic fibrosis induced by Con A in mice.The anti fibrosis mechanisms of the siRNAs maybe associated with the down regulation of TGF-β1,smad3 and a-SMA expression and up regulation of Smad7 expression in liver tissue, which resulted in suppressing the activity of hepatic stellate cells.

  • 【文献出处】 疑难病杂志 ,Chinese Journal of Difficult and Complicated Cases , 编辑部邮箱 ,2010年12期
  • 【分类号】R575.2
  • 【被引频次】4
  • 【下载频次】17
节点文献中: 

本文链接的文献网络图示:

本文的引文网络